Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

Afatinib often causes skin problems that need proactive management.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Voglibose may help treat skin hyperpigmentation safely.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

The herbal extract SHJ promotes hair growth and increases melanin production.

Equisetum debile extracts may help with skin whitening, anti-wrinkle, and anti-hair loss treatments.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

Certain cancer drugs can cause skin issues like rashes and itching.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Quercetin boosts melanin production in mouse hair follicles.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.